Thursday, 23 June 2011

Correction: Germany-Merc

AP - In a story June 22 about German drug maker Merck KGaA dropping its approval bids for multiple sclerosis drug Cladribine, The Associated Press reported erroneously the amount of a charge that Merck will take in the second quarter. The company will take a euro20 million ($28 million) charge.


Related News:-

No comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...